Bio
Aldo Maggioni received his medical degree from the Milan University and performed the cardiology residency at the Padua University. He is a member of the Steering Committee of the…
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
EPH255 Healthcare Resource Consumption of Patients with Cardiovascular Events after Exacerbations of Chronic Obstructive Pulmonary Disease in Italy: Results from the EXACOS-CV Study
Silvia Calabria, Giulia Ronconi, Letizia Dondi, Letizia Dondi, Irene Dell’Anno, Clémentine Nordon, Kirsty Rhodes, Krishnali Parsekar, N. Martini, Aldo Maggioni (2023). EPH255 Healthcare Resource Consumption of Patients with Cardiovascular Events after Exacerbations of Chronic Obstructive Pulmonary Disease in Italy: Results from the EXACOS-CV Study. , 26(12), DOI: https://doi.org/10.1016/j.jval.2023.09.1296.
ArticleyesterdayPrevalence, outcomes and costs of a contemporary, multinational population with heart failure
Anna Norhammar, Johan Bodegård, Marc Vanderheyden, Navdeep Tangri, Avraham Karasik, Aldo Maggioni, Kari Anne Sveen, Tiago Taveira‐Gomes, Manuel Botana, Lukas Hunziker, Marcus Thuresson, Amitava Banerjee, Johan Sundström, Andreas Bollmann (2023). Prevalence, outcomes and costs of a contemporary, multinational population with heart failure. , 109(7), DOI: https://doi.org/10.1136/heartjnl-2022-321702.
ArticleyesterdayVariations in the costs of atrial fibrillation: a longitudinal study across 27 European and Central Asian countries
Marjan Walli-Attaei, Ramón Luengo-Fernández, Alastair Gray, Aleksandra Torbica, Aldo Maggioni, Firoozeh Bairami, Radu Huculeci, Victor Aboyans, Adam Timmis, Panos E. Vardas, José Leal (2023). Variations in the costs of atrial fibrillation: a longitudinal study across 27 European and Central Asian countries. , 44(Supplement_2), DOI: https://doi.org/10.1093/eurheartj/ehad655.3032.
ArticleyesterdayFrailty and outcomes in heart failure patients from high-, middle-, and low-income countries
Darryl P. Leong, Philip Joseph, John J.V. McMurray, Jean L. Rouleau, Aldo Maggioni, Fernando Laņas, Sanjib Kumar Sharma, Julio Núñez, Bishav Mohan, Ahmet Çelik, Jabir Abdullakutty, Okechukwu S. Ogah, Lisa Mielniczuk, Kumar Balasubramanian, Tara McCready, Alex Grinvalds, Salim Yusuf (2023). Frailty and outcomes in heart failure patients from high-, middle-, and low-income countries. , 44(42), DOI: https://doi.org/10.1093/eurheartj/ehad595.
ArticleyesterdayImpact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
PK Judge, Natalie Staplin, KJ Mayne, Christoph Wanner, Julie Green, SJ Hauske, Jonathan Emberson, David Preiss, SYA Ng, AJ Roddick, Emily Sammons, Dandan Zhu, Michael Hill, W. Grant Stevens, Karl Wallendszus, Susanne Brenner, AK Cheung, Zhihong Liu, J Li, LS Hooi, Wenjun Liu, Takashi Kadowaki, Masaomi Nangaku, Adeera Levin, David Z.I. Cherney, Aldo Maggioni, Roberto Pontremoli, Rajat Deo, Shinichi Goto, Xavier Rosselló, Katherine R. Tuttle, Dominik Steubl, Daisy Massey, Martin Landray, Colin Baigent, Richard Haynes, WG Herrington, S Abat, Riaz Rahman, Rizna Abdul Cader, MI Abdul Hafidz, MZ Abdul Wahab, NK Abdullah, Talal Abdulsamad, Masanori Abe, Nader G. Abraham, Sarah Acheampong, P Achiri, JA Acosta, A. Q. Adeleke, Vicki Adell, R Adewuyi-Dalton, Nihad Adnan, A Africano, Mohsen Agharazii, Frank G. Aguilar, A Aguilera, Movahedian Ahmad, MK Ahmad, NA Ahmad, NH Ahmad, NI Ahmad, Norazinizah Ahmad Miswan, H Ahmad Rosdi, Iffat Ahmed, Sofia B. Ahmed, Sofia B. Ahmed, Joan Aiello, A. Aitken, R AitSadi, Sendogan Aker, S Akimoto, A Akinfolarin, S. Akram, Federico Alberici, Christian Albert, Leslie N. Aldrich, M Alegata, Lee Alexander, S Alfaress, Mohammad Alhadj Ali, Ahmed Issam Ali, Ahmed Issam Ali, Radica Z. Alicic, A Aliu, Ricardo López Almaraz, Rashid Almasarwah, Jussara Carnevale de Almeida, Alessia Aloisi, Laith Al‐Rabadi, Mark Dominik Alscher, Pedro Álvarez, Bader Al-Zeer, Mora Amat, Christopher S. Ambrose, Hany Ammar, Yu An, L Andriaccio, Kwame Ansu, A Apostolidi (2023). Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial. , 12(1), DOI: https://doi.org/10.1016/s2213-8587(23)00322-4.
Articleyesterday